Occluder effects on platelet function of patients with congenital heart disease undergoing transcatheter closure
10.3969/j.issn.2095-4344.2014.16.009
- VernacularTitle:封堵器对先天性心脏病封堵患者血小板功能的影响
- Author:
Lin CHEN
;
Hua YAN
;
Liyuan CHEN
;
Yongguang LU
;
Chunhui FU
;
Zhanchuan ZHENG
- Publication Type:Journal Article
- Keywords:
septal occluder device;
heart diseases;
platelet activation;
thrombospondins
- From:
Chinese Journal of Tissue Engineering Research
2014;(16):2512-2518
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUND:Occluder implantation in patients with congenital heart disease can increase in vivo platelet adhesion and aggregation, resulting in thrombosis on the occluder surface. OBJECTIVE:To investigate the effect of the occluder on platelet function in patients with congenital heart disease undergoing transcatheter closure. METHODS: Clinical data from 124 patients with congenital heart disease undergoing transcatheter closure were retrospectively analyzed. These patients were divided into groups of atrial septal defect in 46 cases, patent ductus arteriosus in 43 cases and ventricular septal defect in 35 cases according to the types of congenital heart disease. The positive rates for peripheral blood CD62p, CD63 RESULTS AND CONCLUSION:There was no difference in the positive rates of peripheral blood CD and thrombin sensitive protein were compared before and 6 hours, 24 hours, 12 months after occluder implantation. 62p, CD63 and thrombin sensitive protein among three groups prior to occluder implantation. Up to 6 hours after occluder implantation, the expression levels of peripheral blood CD62p, CD63 and thrombin sensitive protein reached peak in the three groups, especialy in the patients with atrial septal defect and ventricular septal defect, then gradualy decreased. After 12 months, the expression levels of CD62p and CD63 recovered in the patients with patent ductus arteriosus and ventricular septal defect, but stil maintained a higher level in those with atrial septal defect (P < 0.05). The expression of thrombin sensitive protein showed no difference among the three groups at different time. These findings indicate that after occluder implantation, the platelet activation is more remarkable and lasts longer in the patients with atrial septal defect and ventricular septal defect, especialy in those with ventricular septal defect.
